Asian Spine J > Volume 17(1); 2023 > Article |
|
Author Contributions
Analysis of data and drafting manuscript: Madhav R. Patel, Kevin C. Jacob, Kanhai S. Amin, Max A. Ribot; administrative support: Hanna Pawlowski, Michael C. Prabhu, Nisheka N. Vanjani; conception and design, data acquisition, and supervision: Kern Singh; and critical revision: all authors.
Characteristic | Total (n=93) | SF-12 MCS <41 (n=48) | SF-12 MCS ≥41 (n=45) | p-valuea) |
---|---|---|---|---|
Age (yr) | 47.2±9.4 | 46.3±9.6 | 48.1±9.0 | 0.347 |
Body mass index (kg/m2) | 0.126 | |||
<24.9 | 9.7 (9) | 12.5 (6) | 6.7 (3) | |
25.0–29.9 | 34.4 (32) | 25.0 (12) | 44.4 (20) | |
≥30.0 | 55.9 (52) | 62.5 (30) | 48.9 (22) | |
Gender | 0.683 | |||
Female | 17.2 (16) | 18.8 (9) | 15.6 (7) | |
Male | 82.8 (77) | 81.3 (39) | 84.4 (38) | |
Ethnicity | 0.642 | |||
Caucasian | 46.2 (42) | 42.6 (20) | 50.0 (22) | |
African-American | 20.9 (19) | 23.4 (11) | 18.2 (8) | |
Hispanic | 27.5 (25) | 25.5 (12) | 29.6 (13) | |
Asian | 1.1 (1) | 2.1 (1) | 0 | |
Other | 4.4 (4) | 6.4 (3) | 2.3 (1) | |
Diabetic status | 0.440 | |||
Non-diabetic | 86.0 (80) | 83.3 (40) | 88.9 (40) | |
Diabetic | 14.0 (13) | 16.7 (8) | 11.1 (5) | |
Smoking status | 0.653 | |||
Non-smoker | 85.0 (79) | 83.3 (40) | 86.7 (39) | |
Smoker | 15.1 (14) | 16.7 (8) | 13.3 (6) | |
Hypertension status | 0.554 | |||
Normotensive | 69.6 (64) | 72.3 (34) | 66.7 (30) | |
Hypertensive | 30.4 (28) | 27.7 (13) | 33.3 (15) | |
American Society of Anesthesiologists classification | 0.232 | |||
<2 | 19.1 (17) | 23.9 (11) | 14.0 (6) | |
≥2 | 80.9 (72) | 76.1 (35) | 86.1 (37) | |
Charlson comorbidity index score | 1.2±1.2 | 1.2±1.2 | 1.2±1.1 | 0.830 |
Characteristic | Total (n=93) | SF-12 MCS <41 (n=48) | SF-12 MCS ≥41 (n=45) | p-valuea) |
---|---|---|---|---|
Spinal pathology | ||||
Recurrent herniated nucleus pulposus | 29.0 (27) | 18.8 (9) | 40.0 (18) | 0.024 |
Isthmic spondylolisthesis | 22.1 (21) | 25.0 (13) | 18.6 (8) | 0.455 |
Degenerative spondylolisthesis | 36.8 (35) | 34.6 (18) | 39.5 (17) | 0.621 |
Foraminal stenosis | 44.1 (41) | 41.7 (20) | 46.7 (21) | 0.627 |
Central stenosis | 78.5 (73) | 75.0 (36) | 82.2 (37) | 0.397 |
Operative time (min) | 128.3±23.9 | 126.4±24.0 | 130.3±23.9 | 0.436 |
Estimated blood loss (mL) | 49.1±23.1 | 50.1±23.5 | 48.1±22.9 | 0.682 |
Length of stay (hr) | 35.0±23.8 | 38.4±24.8 | 31.5±22.5 | 0.178 |
Postoperative narcotic consumption (OME) | ||||
POD 0 | 65.8±38.8 | 65.3±37.7 | 66.2±40.2 | 0.910 |
POD 1 | 47.9±38.8 | 51.2±39.6 | 44.3±37.9 | 0.399 |
Day of discharge | 0.668 | |||
POD 0 | 23.0 (20) | 18.2 (8) | 27.9 (12) | |
POD 1 | 43.7 (38) | 43.2 (19) | 44.2 (19) | |
POD 2 | 18.4 (16) | 20.5 (9) | 16.3 (7) | |
POD 3 | 13.8 (12) | 15.9 (7) | 11.6 (5) | |
POD 4 | 1.2 (1) | 2.3 (1) | 0 | |
1-Year arthrodesis (computed tomography) | 91.5 (54) | 93.8 (30) | 88.9 (24) | 0.504 |
PROMs | SF-12 MCS <41 (n=48) | p-valuea) | SF-12 MCS ≥41 (n=45) | p-valueb) | p-valuec) |
---|---|---|---|---|---|
PROMIS-PF | |||||
Preoperative | 31.1±5.0 | - | 33.4±6.1 | - | - |
6 Weeks | 31.1±4.8 | 0.674 | 34.1±4.0 | 0.135 | 0.140 |
12 Weeks | 34.6±6.0 | 0.094 | 36.6±6.2 | 0.201 | 0.930 |
6 Months | 36.7±7.4 | 0.010 | 38.4±7.4 | 0.008 | 0.679 |
1 Year | 39.2±8.4 | 0.015 | 39.6±7.6 | 0.037 | 0.360 |
2 Years | 35.2±7.9 | 0.521 | 36.9±10.6 | 0.095 | 0.267 |
SF-12 PCS | |||||
Preoperative | 28.0±5.8 | - | 27.3±9.4 | - | - |
6 Weeks | 27.0±5.9 | 0.856 | 27.6±8.8 | 0.981 | 0.892 |
12 Weeks | 28.4±6.4 | 0.426 | 28.0±7.2 | 0.859 | 0.660 |
6 Months | 28.3±6.2 | 0.711 | 31.7±8.3 | 0.026 | 0.091 |
1 Year | 31.9±10.3 | 0.035 | 31.3±10.3 | 0.268 | 0.843 |
2 Years | 29.2±8.5 | 0.586 | 32.9±13.0 | 0.068 | 0.182 |
SF-12 MCS | |||||
Preoperative | 32.4±6.4 | - | 51.2±6.7 | - | - |
6 Weeks | 38.6±10.3 | 0.002 | 52.4±9.1 | 0.884 | 0.030 |
12 Weeks | 38.5±10.4 | 0.004 | 52.2±10.7 | 0.839 | 0.025 |
6 Months | 38.5±10.7 | 0.002 | 54.9±10.3 | 0.415 | 0.073 |
1 Year | 44.3±11.2 | <0.001 | 51.1±10.1 | 0.267 | <0.001 |
2 Years | 39.8±10.7 | 0.070 | 44.0±13.1 | 0.109 | 0.023 |
VAS back | |||||
Preoperative | 7.5±1.8 | - | 6.7±2.2 | - | - |
6 Weeks | 6.1±2.0 | <0.001 | 5.4±2.1 | <0.001 | 0.844 |
12 Weeks | 6.6±1.9 | 0.009 | 5.0±2.4 | <0.001 | 0.535 |
6 Months | 6.3±2.1 | 0.003 | 4.6±2.5 | <0.001 | 0.066 |
1 Year | 5.4±2.7 | 0.007 | 4.7±2.6 | 0.102 | 0.919 |
2 Years | 5.3±2.9 | 0.031 | 5.5±1.3 | 0.478 | 0.247 |
VAS leg | |||||
Preoperative | 6.7±2.5 | - | 5.7±2.8 | - | - |
6 Weeks | 4.8±3.1 | <0.001 | 4.1±3.1 | 0.037 | 0.297 |
12 Weeks | 5.1±2.4 | 0.001 | 3.7±2.9 | 0.003 | 0.806 |
6 Months | 4.8±2.7 | <0.001 | 3.8±2.8 | <0.001 | 0.561 |
1 Year | 5.0±3.0 | 0.005 | 3.4±2.7 | 0.134 | 0.761 |
2 Years | 4.6±4.2 | 0.084 | 3.4±2.7 | 0.013 | 0.843 |
ODI | |||||
Preoperative | 56.4±15.5 | - | 46.0±13.8 | - | - |
6 Weeks | 55.2±15.7 | 0.811 | 46.4±16.1 | 0.694 | 0.669 |
12 Weeks | 50.0±13.6 | 0.005 | 40.4±15.1 | 0.046 | 0.303 |
6 Months | 46.3±14.3 | <0.001 | 35.9±19.3 | <0.001 | 0.679 |
1 Year | 42.0±21.4 | 0.003 | 30.5±18.0 | 0.069 | 0.806 |
2 Years | 48.3±28.9 | 0.812 | 40.9±20.7 | 0.179 | 0.268 |
Values are presented as mean±standard deviation, unless otherwise stated. Boldface indicates statistical significance.
SF-12 MCS, 12-item Short Form Mental Composite Scale; PROMs, patient-reported outcome measures; PROMIS-PF, Patient-Reported Outcomes Measurement Information System Physical Function; SF-12 PCS, 12-item Short Form Physical Composite Scale; VAS, Visual Analog Scale; ODI, Oswestry Disability Index.
a) Calculated using paired samples t-test to determine improvement from preoperative to postoperative PROMs among SF-12 MCS <41 cohort.
PROMs | SF-12 MCS <41 (n=48) | SF-12 MCS ≥41 (n=45) | p-valuea) | p-valueb) |
---|---|---|---|---|
PROMIS-PF | ||||
Preoperative | 31.1±5.0 | 33.4±6.1 | 0.310 | 0.510 |
6 Weeks | 31.1±4.8 | 34.1±4.0 | 0.068 | 0.022 |
12 Weeks | 34.6±6.0 | 36.6±6.2 | 0.364 | 0.930 |
6 Months | 36.7±7.4 | 38.4±7.4 | 0.536 | 0.208 |
1 Year | 39.2±8.4 | 39.6±7.6 | 0.687 | 0.503 |
2 Years | 35.2±7.9 | 36.9±10.6 | 0.726 | 0.868 |
SF-12 PCS | ||||
Preoperative | 28.0±5.8 | 27.3±9.4 | 0.671 | 0.247 |
6 Weeks | 27.0±5.9 | 27.6±8.8 | 0.768 | 0.665 |
12 Weeks | 28.4±6.4 | 28.0±7.2 | 0.810 | 0.759 |
6 Months | 28.3±6.2 | 31.7±8.3 | 0.156 | 0.235 |
1 Year | 31.9±10.3 | 31.3±10.3 | 0.862 | 0.750 |
2 Years | 29.2±8.5 | 32.9±13.0 | 0.467 | 0.835 |
SF-12 MCS | ||||
Preoperative | 32.4±6.4 | 51.2±6.7 | <0.001 | <0.001 |
6 Weeks | 38.6±10.3 | 52.4±9.1 | <0.001 | <0.001 |
12 Weeks | 38.5±10.4 | 52.2±10.7 | <0.001 | <0.001 |
6 Months | 38.5±10.7 | 54.9±10.3 | <0.001 | 0.001 |
1 Year | 44.3±11.2 | 51.1±10.1 | 0.074 | 0.313 |
2 Years | 39.8±10.7 | 44.0±13.1 | 0.436 | 0.816 |
VAS back | ||||
Preoperative | 7.5±1.8 | 6.7±2.2 | 0.081 | 0.342 |
6 Weeks | 6.1±2.0 | 5.4±2.1 | 0.165 | 0.319 |
12 Weeks | 6.6±1.9 | 5.0±2.4 | 0.005 | 0.056 |
6 Months | 6.3±2.1 | 4.6±2.5 | 0.002 | 0.021 |
1 Year | 5.4±2.7 | 4.7±2.6 | 0.461 | 0.185 |
2 Years | 5.3±2.9 | 5.5±1.3 | 0.904 | 0.730 |
VAS leg | ||||
Preoperative | 6.7±2.5 | 5.7±2.8 | 0.091 | 0.091 |
6 Weeks | 4.8±3.1 | 4.1±3.1 | 0.332 | 0.753 |
12 Weeks | 5.1±2.4 | 3.7±2.9 | 0.029 | 0.287 |
6 Months | 4.8±2.7 | 3.8±2.8 | 0.118 | 0.444 |
1 Year | 5.0±3.0 | 3.4±2.7 | 0.148 | 0.053 |
2 Years | 4.6±4.2 | 3.4±2.7 | 0.527 | 0.885 |
ODI | ||||
Preoperative | 56.4±15.5 | 46.0±13.8 | 0.001 | 0.007 |
6 Weeks | 55.2±15.7 | 46.4±16.1 | 0.018 | 0.043 |
12 Weeks | 50.0±13.6 | 40.4±15.1 | 0.008 | 0.039 |
6 Months | 46.3±14.3 | 35.9±19.3 | 0.011 | 0.084 |
1 Year | 42.0±21.4 | 30.5±18.0 | 0.119 | 0.117 |
2 Years | 48.3±28.9 | 40.9±20.7 | 0.584 | 0.951 |
Values are presented as mean±standard deviation, unless otherwise stated. Boldface indicates statistical significance.
PROMsa) | SF-12 MCS <41 (n=48) | SF-12 MCS ≥41 (n=45) | p-valueb) |
---|---|---|---|
ODI | |||
6 Weeks | 20.5 | 11.4 | 0.290 |
12 Weeks | 34.4 | 15.2 | 0.072 |
6 Months | 51.4 | 28.6 | 0.051 |
1 Year | 35.0 | 30.8 | 0.801 |
2 Years | 0 | 28.6 | 0.104 |
Overall | 53.3 (24) | 31.7 (13) | 0.043 |
PROMIS-PF | |||
6 Weeks | 17.7 | 66.7 | 0.331 |
12 Weeks | 28.6 | 23.1 | 0.745 |
6 Months | 61.5 | 36.4 | 0.219 |
1 Year | 50.0 | 62.5 | 0.571 |
2 Years | 37.5 | 42.9 | 0.833 |
Overall | 66.7 (14) | 50.0 (9) | 0.291 |
SF-12 PCS | |||
6 Weeks | 37.0 | 22.7 | 0.280 |
12 Weeks | 43.5 | 36.0 | 0.597 |
6 Months | 35.0 | 45.0 | 0.519 |
1 Year | 66.7 | 50.0 | 0.324 |
2 Years | 33.3 | 58.3 | 0.256 |
Overall | 66.7 (24) | 63.6 (21) | 0.792 |
SF-12 MCS | |||
6 Weeks | 44.4 | 16.7 | 0.033 |
12 Weeks | 34.8 | 18.5 | 0.191 |
6 Months | 45.0 | 20.0 | 0.091 |
1 Year | 72.2 | 6.3 | <0.001 |
2 Years | 33.3 | 25.0 | 0.676 |
Overall | 66.7 (24) | 28.6 (10) | 0.001 |
VAS back | |||
6 Weeks | 30.8 | 33.3 | 0.812 |
12 Weeks | 29.0 | 36.4 | 0.532 |
6 Months | 20.6 | 54.3 | 0.004 |
1 Year | 30.0 | 53.9 | 0.171 |
2 Years | 37.5 | 42.9 | 0.833 |
Overall | 48.9 (22) | 69.1 (29) | 0.056 |
VAS leg | |||
6 Weeks | 37.8 | 33.3 | 0.695 |
12 Weeks | 35.5 | 30.3 | 0.659 |
6 Months | 44.1 | 42.9 | 0.916 |
1 Year | 25.0 | 46.2 | 0.208 |
2 Years | 57.1 | 50.0 | 0.797 |
Overall | 55.8 (24) | 52.5 (21) | 0.762 |
MCID, minimal clinically important difference; PROMs, patient-reported outcome measures; SF-12 MCS, 12-item Short Form Mental Composite Scale; ODI, Oswestry Disability Index; PROMIS-PF, Patient-Reported Outcomes Measurement Information System Physical Function; SF-12 PCS, 12-item Short Form Physical Composite Scale; VAS, Visual Analog Scale.